Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
about
Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditionsAn exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model.Immunopathogenesis of osteoarthritisThe role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model.Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes.Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos inductionThe identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383.Leptin induces IL-6 expression through OBRl receptor signaling pathway in human synovial fibroblasts.The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.MicroRNA-9 promotion of interleukin-6 expression by inhibiting monocyte chemoattractant protein-induced protein 1 expression in interleukin-1β-stimulated human chondrocytesIncreased expression of IL-6 family members in tendon pathologyMetabolic Response of Human Osteoarthritic Cartilage to Biochemically Characterized Collagen Hydrolysates.miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes.Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13.The effects of adipokines on cartilage and meniscus catabolismCells of the synovium in rheumatoid arthritis. Chondrocytes.Metalloproteases as potential therapeutic targets in arthritis treatment.Cartilage homeostasis in health and rheumatic diseases.Inhibition of transforming growth factor β-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritisThe enigmatic cytokine oncostatin m and roles in diseaseObesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis.Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown.The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism.Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration modelRegulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells.Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines.Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent.A novel paradigm for dendritic cells as effectors of cartilage destruction.Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.The Role of Athletic Trainers in Preventing and Managing Posttraumatic Osteoarthritis in Physically Active Populations: a Consensus Statement of the Athletic Trainers' Osteoarthritis Consortium.Calcitonin gene-related peptide can be selected as a predictive biomarker on progression and prognosis of knee osteoarthritis.Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation.
P2860
Q26852836-68CA839C-D0C0-40AA-8872-0A03D46B3AC5Q33485570-6171082F-E5B1-4B01-9B5C-6A392C978E26Q33587966-BE324207-197E-4A2B-8CE8-B30D1AFA64C1Q33614316-8C0C0F50-AA56-4208-B747-2F685B8BB521Q33734592-4F5A4E6C-0265-4A8B-825D-00F2CB5D7BF2Q33766376-E6E693CB-8431-4326-A4B1-ABC811DFBDAAQ33991241-F10DAF24-9012-483C-BE3A-FDEC5610AF16Q34795530-B6C49A9B-2EC6-4F32-A175-81CB6453538CQ35005738-B77D5E10-AF5C-4022-A43B-2D35DDF0822DQ35092953-16536058-A6ED-4FBA-B114-9E1033BCE59AQ35901101-8F86478C-345B-4D42-BAF7-C211D61AB222Q36049631-AFB7E535-1358-4F44-895D-8CC6DDC19175Q36258538-7BE44E79-FEF2-49D6-B668-20EFEAA058EFQ36356966-542C0083-7A6B-4812-97DD-4C8958F7BC53Q36641543-5E0B7A75-8D94-4DBE-AA88-B653CF1E11CBQ36741296-3AD3ABED-3E83-4D34-96C3-AB3D3D8B8A4CQ37000837-EB3A97C7-2D70-405A-AA15-12302819FECEQ37030862-D30E4C6B-F89A-47D8-88D6-301CBD0F9BF1Q37270714-755DE730-FCD6-4884-9999-B63CFD47367BQ37294091-F896E56C-DC4B-4050-BE51-92F096C145ACQ37409222-C03C9979-549D-4FEC-A9C0-9D46D6C1A7E3Q38287819-ADEE4754-53A7-484F-9279-C31E3054968CQ39563568-8CD40B45-1073-40C9-95A7-9451800634AAQ39609958-6E4DA9A1-3E16-4FF3-9167-E261D7CF0222Q39937956-BC8816DD-6841-4554-82C3-213E80D78244Q40738183-8070B661-065A-48D9-B890-D07010FE6006Q40773551-6C98D5DA-366F-48B1-B996-363D2CE5DFD8Q41866942-0AFF8539-B43F-4FC8-BCC8-940F83E8D7DFQ41901416-351EC754-7EB6-4644-A03F-AB1E31C1CD1CQ42012743-DA5F0C69-BBA4-4B3D-BA5B-C222F8FD0910Q42047774-1A4C1694-8DFF-4810-B0BE-CE408A3E6391Q42106805-0647D0E6-7EA5-451C-9AD1-1AFCE5E6634EQ42540679-02174C0D-1F59-4D44-BF2F-CAB872733A31Q43081525-535B2D59-4458-4DFE-8DA7-27D01B6DF4B9Q45911906-1A5E6CF5-41C4-43CB-9411-73F001D1F2AEQ46095815-0A4538D9-5508-4C6F-8176-855108AE7B1CQ46563144-5C430CAA-3BD0-48C7-A2E8-D571945438D9Q47844181-120F2154-A277-4D6A-B64D-E0DDB56F35ABQ50575255-834D0C1B-EBA3-4E45-9606-DC40A71959D3Q51015488-D0A49093-038B-4CC2-A05B-770486F90F56
P2860
Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Synergistic effects of glycopr ...... cartilage collagen breakdown.
@en
type
label
Synergistic effects of glycopr ...... cartilage collagen breakdown.
@en
prefLabel
Synergistic effects of glycopr ...... cartilage collagen breakdown.
@en
P2093
P2860
P1476
Synergistic effects of glycopr ...... cartilage collagen breakdown.
@en
P2093
A B Vernallis
B A Degnan
J R Spaull
T E Cawston
W D Shingleton
P2860
P304
P356
10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B
P577
2001-07-01T00:00:00Z